Cargando…
Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trial
BACKGROUND: Psoriasis prevalence and characteristics in Asia, Central Europe, and Latin America have not been thoroughly investigated and there are no large trials for biologic treatments for patients from these regions. The goal of this analysis was to report clinical response to anti-tumor necrosi...
Autores principales: | Kemeny, L., Amaya, M., Cetkovska, P., Rajatanavin, N., Lee, W-R., Szumski, A., Marshall, L., Mahgoub, E. Y., Aldinç, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494170/ https://www.ncbi.nlm.nih.gov/pubmed/25994179 http://dx.doi.org/10.1186/s12895-015-0028-8 |
Ejemplares similares
-
Studies on Asia and Africa from Latin America
Publicado: (1990) -
Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009) -
The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc analysis from PRISTINE and PRESTA
por: Walsh, Jessica A, et al.
Publicado: (2018) -
HELEN network unites Europe and Latin America
Publicado: (2005) -
The safety of etanercept for the treatment of plaque psoriasis
por: Papp, Kim A
Publicado: (2007)